CMMB Stock Summary and Trading Ideas (Chemomab Therapeutics Ltd. - American Depositary Shares | NASDAQ:CMMB)

Chemomab Therapeutics Ltd is a clinical-stage biotechnology company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases.

Chemomab Therapeutics Ltd. - American Depositary Shares trades on the NASDAQ stock market under the symbol CMMB.

As of September 4, 2026, CMMB stock price declined to $2.71 with 108,230 million shares trading.

CMMB has a beta of 1.82, meaning it tends to be more sensitive to market movements. CMMB has a correlation of 0.07 to the broad based SPY ETF.

CMMB has a market cap of $19.86 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, CMMB traded as high as $10.20 and as low as $1.35.

CMMB has underperformed the market in the last year with a return of -11.1%, while SPY returned +19.8%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in CMMB shares. However, CMMB has outperformed the market in the last 3 month and 2 week periods, returning +50.6% and +25.5%, while SPY returned +2.0% and +0.6%, respectively. This indicates CMMB has been having a stronger performance recently.

CMMB support price is $2.67 and resistance is $2.99 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CMMB shares will trade within this expected range on the day.